Por: Orlando Sentinel Nation January 20, 2023
Central Florida residents now have access to the first-ever treatment to delay Type 1 diabetes. In November, the U.S. Food and Drug Administration approved Provention Bio and Sanofi’s monoclonal antibody teplizumab — marketed as Tzield, for prediabetic adults and children over 8. A clinical trial found this drug prevented the onset of this disease in prediabetic people for an average of about two years. AdventHealth Orlando helped screen... + full article
Los Angeles Times USA Science December 23, 2022
For more than a month, Shane Anthony, a 57-year-old auto mechanic, hasn’t been able to get his diabetes medication. Ozempic, an injection that keeps blood sugar levels in check for patients with Type 2 diabetes, has been in shortage for about four months, according to the... + más
What To Know About Ozempic: The Diabetes Drug Becomes A Viral Weight Loss Hit (Elon Musk Boasts Using It) Creating A Shortage | Forbes
What to know about Ozempic as demand for the drug leads to shortage | ABC News
RTTNews USA Health November 18, 2022
The U.S. Food and Drug Administration said it has approved Provention Bio Inc.'s Tzield (teplizumab-mzwv) injection to delay the onset of stage 3 type 1 diabetes in adults and pediatric patients 8 years and older who currently have stage 2 type 1 diabetes.In pre-market... + más
FDA approves 1st drug to delay onset of Type 1 diabetes | ABC News
FDA approves 1st drug to delay the onset of Type 1 diabetes | NBC News
ABC News USA Health November 18, 2022
For the first time, the U.S. Food and Drug Administration on Thursday approved a treatment that can delay the onset of .Teplizumab, a monoclonal antibody that will be marketed under the brand name Tzield from pharmaceutical companies ProventionBio and Sanofi, is administered... + más
FDA Oks Provention Bio's Tzield To Delay Onset Of Type 1 Diabetes | RTTNews
NBC News USA Nation November 18, 2022
The Food and Drug Administration on Thursday approved the first drug to delay the onset of Type 1 diabetes. The drug, called Tzield, is a monoclonal antibody injection. It’s been approved for people ages 8 and older who have early signs of Type 1 diabetes. Nearly 2 million... + más
Forbes USA Tech November 15, 2022
A young girl with diabetes injects herself with insulin. getty Twenty thousand U.K. children will be screened for type one diabetes in a landmark study that could lead to a national scheme. The (EarLy Surveillance for Autoimmune diabetes) program will use blood tests to identify... + más
Do Statins Increase the Risk of Diabetes? | The New York Times
What to Know About Bariatric Surgery for Type 2 Diabetes | Time
Time USA Health November 04, 2022
The term bariatric is derived from the Greek words for “weight” and “to treat.” Originally, as its name denotes, this form of surgery was aimed at helping people manage obesity. But as medical science’s understanding of bariatric surgery improved, experts recognized... + más
Why people with diabetes are more likely to suffer dreaded ‘trigger finger’ | New York Post
The New York Times USA Health October 25, 2022
Q: Do statins increase the risk of Type 2 diabetes?If you’re among the tens of millions of Americans who could and yet don’t take one, your hesitance may partly stem from worries about its side effects, said Dr. Savitha Subramanian, an endocrinologist at the University of... + más
Women with diabetes almost twice as likely to die prematurely: Study | Newsweek
About iurex | Privacy Policy | Disclaimer |